Position in MGNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$230,213
+$49,222 QoQ
Shares Held
49,830
-20.4% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Derivatives in MGNX
reported options exposure · as of Jun 30, 2024CallValue
$21,250
CallShares
5,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. MGNX ranks #213 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in MGNX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $230,213 | 49,830 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $180,991 | 62,627 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $66,573 | 41,350 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $66,033 | 39,306 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $69,959 | 57,818 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $139,873 | 110,137 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $363,645 | 111,891 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $324,896 | 98,753 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $21,250 | 5,000 | Call | Sole | 2026-03-23 | |
| 2024-06-30 | $191,733 | 45,114 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $1,203,241 | 81,742 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $1,515,447 | 157,531 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $625,711 | 134,273 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $623,488 | 116,540 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,004,860 | 140,148 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $878,479 | 130,921 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $211,250 | 61,055 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $188,651 | 63,950 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $344,092 | 39,057 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,215,241 | 75,716 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,403,670 | 67,033 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,929,971 | 71,853 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,403,331 | 106,855 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $457,450 | 20,011 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $671,111 | 26,642 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,603,651 | 93,254 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $99,079 | 17,024 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||